Related Experiment Video
Updated: Mar 16, 2026

Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
Published on: February 16, 2022
Nanoparticulated Nitric Oxide Donors and their Biomedical Applications
Amedea B Seabra1, Nelson Duran
1Human and Natural Sciences Center, Universidade Federal do ABC, UFABC, Santo André, SP, CEP 09210-580,. Brazil.
Abstract:
The small molecule nitric oxide (NO) plays important roles in many vital physiological and pathophysiological processes, including the modulation of cardiovascular processes, and key functions in the immune, nervous e respiratory systems. Several pathological conditions, such as sexual dysfunction and hypertension, are associated with deficiencies in the NO production or its inactivation. Due to the relative instability of NO in biological system, there is an increasing interest in the preparation of NO carriers as an efficient platform to carry and deliver therapeutic and relevant amounts of NO in biomedical applications. Among these approaches, NO-releasing nanomaterials have been described as promising strategy that could promote the spatio-temporal production of NO, in several pharmacological applications. The scope of this review is to point out the recent advances in the synthesis of versatile NO-releasing nanomaterials based on several materials, including polymeric nanoparticles, dendrimers, liposomes, solid lipid nanoparticles, metallic nanoparticles, silica nanoparticles, and carbon nanotubes. Although important progress in this area, some drawbacks still need to be overcome in order to translate these research innovations into practical applications. In this scenario, this review describes the state of the art of versatile nanostructured NO donors and their biomedical applications.
Related Concept Videos
Nitric Oxide Signaling Pathway
Antihypertensive Drugs: Vasodilators
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Drug Delivery: Enteral Route

